Clinical Trial Update: A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating HS-10374 for moderate to severe plaque psoriasis to assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• HS-10374

Snippet

Sponsor: Hansoh BioMedical R&D Company | Conditions: Psoriasis | Phase 2 | Status: UNKNOWN